Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 84

1.

Technical Note: Feasibility study of titanium markers in choroidal melanoma localization for proton beam radiation therapy.

Daftari IK, Quivey JM, Chang JS, Mishra KK.

Med Phys. 2018 Mar;45(3):1036-1039. doi: 10.1002/mp.12764. Epub 2018 Feb 7.

PMID:
29377168
2.

Temporal Evolution and Dose-Volume Histogram Predictors of Visual Acuity After Proton Beam Radiation Therapy of Uveal Melanoma.

Polishchuk AL, Mishra KK, Weinberg V, Daftari IK, Nguyen JM, Cole TB, Quivey JM, Phillips TL, Char DH.

Int J Radiat Oncol Biol Phys. 2017 Jan 1;97(1):91-97. doi: 10.1016/j.ijrobp.2016.09.019. Epub 2016 Sep 23.

PMID:
27838186
3.

Impact of Neuroradiology-Based Peer Review on Head and Neck Radiotherapy Target Delineation.

Braunstein S, Glastonbury CM, Chen J, Quivey JM, Yom SS.

AJNR Am J Neuroradiol. 2017 Jan;38(1):146-153. doi: 10.3174/ajnr.A4963. Epub 2016 Nov 3.

4.
5.

Does radiation dose matter in thyroid cancer?: Patterns of local-regional failure in recurrent and metastatic well-differentiated thyroid cancers treated with dose-painted intensity-modulated radiation therapy.

Shugard E, Chen J, Quivey JM, Glastonbury CM, Khanafshar E, Garsa AA, George JR, Yom SS.

J Med Imaging Radiat Oncol. 2016 Aug;60(4):560-7. doi: 10.1111/1754-9485.12452. Epub 2016 Mar 28.

PMID:
27020481
6.

In Reply to Kamrava and McCannel.

Mishra KK, Quivey JM, Daftari IK, Weinberg V, Castro JR, Phillips TL, Char DH.

Int J Radiat Oncol Biol Phys. 2015 Sep 1;93(1):216-7. doi: 10.1016/j.ijrobp.2015.04.045. No abstract available.

PMID:
26279045
7.

Long-term Results of the UCSF-LBNL Randomized Trial: Charged Particle With Helium Ion Versus Iodine-125 Plaque Therapy for Choroidal and Ciliary Body Melanoma.

Mishra KK, Quivey JM, Daftari IK, Weinberg V, Cole TB, Patel K, Castro JR, Phillips TL, Char DH.

Int J Radiat Oncol Biol Phys. 2015 Jun 1;92(2):376-83. doi: 10.1016/j.ijrobp.2015.01.029. Epub 2015 Apr 1.

PMID:
25841624
8.

Dosimetric predictors of hypothyroidism in oropharyngeal cancer patients treated with intensity-modulated radiation therapy.

Chyan A, Chen J, Shugard E, Lambert L, Quivey JM, Yom SS.

Radiat Oncol. 2014 Dec 5;9:269. doi: 10.1186/s13014-014-0269-4.

9.

Risk factors for neovascular glaucoma after proton beam therapy of uveal melanoma: a detailed analysis of tumor and dose-volume parameters.

Mishra KK, Daftari IK, Weinberg V, Cole T, Quivey JM, Castro JR, Phillips TL, Char DH.

Int J Radiat Oncol Biol Phys. 2013 Oct 1;87(2):330-6. doi: 10.1016/j.ijrobp.2013.05.051. Epub 2013 Jul 23.

PMID:
23886415
10.

Dosimetric evaluation of automatic segmentation for adaptive IMRT for head-and-neck cancer.

Tsuji SY, Hwang A, Weinberg V, Yom SS, Quivey JM, Xia P.

Int J Radiat Oncol Biol Phys. 2010 Jul 1;77(3):707-14. doi: 10.1016/j.ijrobp.2009.06.012. Epub 2010 Mar 16.

PMID:
20231063
11.

Can positron emission tomography (PET) or PET/Computed Tomography (CT) acquired in a nontreatment position be accurately registered to a head-and-neck radiotherapy planning CT?

Hwang AB, Bacharach SL, Yom SS, Weinberg VK, Quivey JM, Franc BL, Xia P.

Int J Radiat Oncol Biol Phys. 2009 Feb 1;73(2):578-84. doi: 10.1016/j.ijrobp.2008.09.041. Epub 2008 Dec 10.

PMID:
19084350
12.

Assessment of carotid artery dose in the treatment of nasopharyngeal cancer with IMRT versus conventional radiotherapy.

Vitolo V, Millender LE, Quivey JM, Yom SS, Schechter NR, Jereczek-Fossa BA, Milani F, Orecchia R, Xia P.

Radiother Oncol. 2009 Feb;90(2):213-20. doi: 10.1016/j.radonc.2008.08.014. Epub 2008 Oct 14.

PMID:
18926579
13.

Intensity-modulated chemoradiation for treatment of stage III and IV oropharyngeal carcinoma: the University of California-San Francisco experience.

Huang K, Xia P, Chuang C, Weinberg V, Glastonbury CM, Eisele DW, Lee NY, Yom SS, Phillips TL, Quivey JM.

Cancer. 2008 Aug 1;113(3):497-507. doi: 10.1002/cncr.23578.

14.

Nonfunctioning parathyroid carcinoma: case report and review of literature.

Fernandez-Ranvier GG, Jensen K, Khanafshar E, Quivey JM, Glastonbury C, Kebebew E, Duh QY, Clark OH.

Endocr Pract. 2007 Nov-Dec;13(7):750-7. Review.

PMID:
18194932
15.

A treatment planning analysis of inverse-planned and forward-planned intensity-modulated radiation therapy in nasopharyngeal carcinoma.

Poon I, Xia P, Weinberg V, Sultanem K, Akazawa C, Akazawa P, Verhey L, Quivey JM, Lee N.

Int J Radiat Oncol Biol Phys. 2007 Dec 1;69(5):1625-33.

PMID:
18035216
16.

Detection of treatment setup errors between two CT scans for patients with head and neck cancer.

Ezzell LC, Hansen EK, Quivey JM, Xia P.

Med Phys. 2007 Aug;34(8):3233-42.

PMID:
17879786
17.

Simplifying intensity-modulated radiotherapy plans with fewer beam angles for the treatment of oropharyngeal carcinoma.

Takamiya R, Missett B, Weinberg V, Akazawa C, Akazawa P, Zytkovicz A, Bucci MK, Lee N, Quivey JM, Xia P.

J Appl Clin Med Phys. 2007 Apr 11;8(2):26-36.

18.

Carcinomas of the paranasal sinuses and nasal cavity treated with radiotherapy at a single institution over five decades: are we making improvement?

Chen AM, Daly ME, Bucci MK, Xia P, Akazawa C, Quivey JM, Weinberg V, Garcia J, Lee NY, Kaplan MJ, El-Sayed I, Eisele DW, Fu KK, Phillips TL.

Int J Radiat Oncol Biol Phys. 2007 Sep 1;69(1):141-7. Epub 2007 Apr 24.

PMID:
17459609
19.

A phase II study of fixed-dose rate gemcitabine plus low-dose cisplatin followed by consolidative chemoradiation for locally advanced pancreatic cancer.

Ko AH, Quivey JM, Venook AP, Bergsland EK, Dito E, Schillinger B, Tempero MA.

Int J Radiat Oncol Biol Phys. 2007 Jul 1;68(3):809-16. Epub 2007 Mar 23.

PMID:
17363191
20.

Recurrent pleomorphic adenoma of the parotid gland: long-term outcome of patients treated with radiation therapy.

Chen AM, Garcia J, Bucci MK, Quivey JM, Eisele DW.

Int J Radiat Oncol Biol Phys. 2006 Nov 15;66(4):1031-5.

PMID:
17145531
21.

The role of postoperative radiation therapy in carcinoma ex pleomorphic adenoma of the parotid gland.

Chen AM, Garcia J, Bucci MK, Quivey JM, Eisele DW.

Int J Radiat Oncol Biol Phys. 2007 Jan 1;67(1):138-43. Epub 2006 Oct 16.

PMID:
17049183
22.

Long-term outcome of patients treated by radiation therapy alone for salivary gland carcinomas.

Chen AM, Bucci MK, Quivey JM, Garcia J, Eisele DW, Fu KK.

Int J Radiat Oncol Biol Phys. 2006 Nov 15;66(4):1044-50. Epub 2006 Sep 11.

PMID:
16965870
23.

Adenoid cystic carcinoma of the head and neck treated by surgery with or without postoperative radiation therapy: prognostic features of recurrence.

Chen AM, Bucci MK, Weinberg V, Garcia J, Quivey JM, Schechter NR, Phillips TL, Fu KK, Eisele DW.

Int J Radiat Oncol Biol Phys. 2006 Sep 1;66(1):152-9.

PMID:
16904520
24.

Repeat CT imaging and replanning during the course of IMRT for head-and-neck cancer.

Hansen EK, Bucci MK, Quivey JM, Weinberg V, Xia P.

Int J Radiat Oncol Biol Phys. 2006 Feb 1;64(2):355-62. Epub 2005 Oct 26.

PMID:
16256277
25.

Method to account for dose fractionation in analysis of IMRT plans: modified equivalent uniform dose.

Park CS, Kim Y, Lee N, Bucci KM, Quivey JM, Verhey LJ, Xia P.

Int J Radiat Oncol Biol Phys. 2005 Jul 1;62(3):925-32.

PMID:
15936579
26.

A study of planning dose constraints for treatment of nasopharyngeal carcinoma using a commercial inverse treatment planning system.

Xia P, Lee N, Liu YM, Poon I, Weinberg V, Shin E, Quivey JM, Verhey LJ.

Int J Radiat Oncol Biol Phys. 2004 Jul 1;59(3):886-96.

PMID:
15183492
27.

A forward-planned treatment technique using multisegments in the treatment of head-and-neck cancer.

Lee N, Akazawa C, Akazawa P, Quivey JM, Tang C, Verhey LJ, Xia P.

Int J Radiat Oncol Biol Phys. 2004 Jun 1;59(2):584-94.

PMID:
15145180
28.

Managing nasopharyngeal carcinoma with intracavitary brachytherapy: one institution's 45-year experience.

Lee N, Hoffman R, Phillips TL, Xia P, Quivey JM, Weinberg V, Hsu IC.

Brachytherapy. 2002;1(2):74-82.

PMID:
15062174
29.

Management of cervical metastases in advanced squamous cell carcinoma of the base of tongue.

Pletcher SD, Kaplan MJ, Eisele DW, Singer MI, Quivey JM, Lee N.

Arch Otolaryngol Head Neck Surg. 2003 Sep;129(9):983-6.

PMID:
12975272
30.

Intensity-modulated radiation therapy for head-and-neck cancer: the UCSF experience focusing on target volume delineation.

Lee N, Xia P, Fischbein NJ, Akazawa P, Akazawa C, Quivey JM.

Int J Radiat Oncol Biol Phys. 2003 Sep 1;57(1):49-60.

PMID:
12909215
31.

The American Brachytherapy Society recommendations for brachytherapy of uveal melanomas.

Nag S, Quivey JM, Earle JD, Followill D, Fontanesi J, Finger PT; American Brachytherapy Society.

Int J Radiat Oncol Biol Phys. 2003 Jun 1;56(2):544-55.

PMID:
12738332
32.

Comparison of treatment plans using intensity-modulated radiotherapy and three-dimensional conformal radiotherapy for paranasal sinus carcinoma.

Huang D, Xia P, Akazawa P, Akazawa C, Quivey JM, Verhey LJ, Kaplan M, Lee N.

Int J Radiat Oncol Biol Phys. 2003 May 1;56(1):158-68.

PMID:
12694834
33.
34.

Skin toxicity due to intensity-modulated radiotherapy for head-and-neck carcinoma.

Lee N, Chuang C, Quivey JM, Phillips TL, Akazawa P, Verhey LJ, Xia P.

Int J Radiat Oncol Biol Phys. 2002 Jul 1;53(3):630-7.

PMID:
12062606
35.

Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience.

Lee N, Xia P, Quivey JM, Sultanem K, Poon I, Akazawa C, Akazawa P, Weinberg V, Fu KK.

Int J Radiat Oncol Biol Phys. 2002 May 1;53(1):12-22.

PMID:
12007936
36.

Treatment results and prognostic factors of advanced T3--4 laryngeal carcinoma: the University of California, San Francisco (UCSF) and Stanford University Hospital (SUH) experience.

Nguyen-Tan PF, Le QT, Quivey JM, Singer M, Terris DJ, Goffinet DR, Fu KK.

Int J Radiat Oncol Biol Phys. 2001 Aug 1;50(5):1172-80.

PMID:
11483326
37.

Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival.

Haigh PI, Ituarte PH, Wu HS, Treseler PA, Posner MD, Quivey JM, Duh QY, Clark OH.

Cancer. 2001 Jun 15;91(12):2335-42.

PMID:
11413523
38.

Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience.

Sultanem K, Shu HK, Xia P, Akazawa C, Quivey JM, Verhey LJ, Fu KK.

Int J Radiat Oncol Biol Phys. 2000 Oct 1;48(3):711-22.

PMID:
11020568
39.

Dose optimization for the treatment of anaplastic thyroid carcinoma: a comparison of treatment planning techniques.

Posner MD, Quivey JM, Akazawa PF, Xia P, Akazawa C, Verhey LJ.

Int J Radiat Oncol Biol Phys. 2000 Sep 1;48(2):475-83.

PMID:
10974465
40.

Metastatic risk for distinct patterns of postirradiation local recurrence of posterior uveal melanoma.

Harbour JW, Char DH, Kroll S, Quivey JM, Castro J.

Ophthalmology. 1997 Nov;104(11):1785-92; discussion 1792-3.

PMID:
9373108
41.

15 years experience with helium ion radiotherapy for uveal melanoma.

Castro JR, Char DH, Petti PL, Daftari IK, Quivey JM, Singh RP, Blakely EA, Phillips TL.

Int J Radiat Oncol Biol Phys. 1997 Dec 1;39(5):989-96.

PMID:
9392536
42.

Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma.

Le QT, Fu KK, Kroll S, Ryu JK, Quivey JM, Meyler TS, Krieg RM, Phillips TL.

Int J Radiat Oncol Biol Phys. 1997 Aug 1;39(1):115-26.

PMID:
9300746
43.

125I plaque therapy for uveal melanoma. Analysis of the impact of time and dose factors on local control.

Quivey JM, Augsburger J, Snelling L, Brady LW.

Cancer. 1996 Jun 1;77(11):2356-62.

PMID:
8635107
44.
45.

31P magnetic resonance spectroscopy after combined hyperthermia and radiation.

Kurhanewicz J, Char DH, Stauffer P, Quivey JM, James TL.

Curr Eye Res. 1994 Feb;13(2):151-6.

PMID:
8194362
46.

Carcinoma of the cervix: predictive value of clinical and magnetic resonance (MR) imaging assessment of prognostic factors.

Hricak H, Quivey JM, Campos Z, Gildengorin V, Hindmarsh T, Bis KG, Stern JL, Phillips TL.

Int J Radiat Oncol Biol Phys. 1993 Nov 15;27(4):791-801.

PMID:
8244807
47.

Irradiation of the cervix uteri: value of unenhanced and contrast-enhanced MR imaging.

Hricak H, Swift PS, Campos Z, Quivey JM, Gildengorin V, Göranson H.

Radiology. 1993 Nov;189(2):381-8.

PMID:
8210364
48.

Helium ions versus iodine 125 brachytherapy in the management of uveal melanoma. A prospective, randomized, dynamically balanced trial.

Char DH, Quivey JM, Castro JR, Kroll S, Phillips T.

Ophthalmology. 1993 Oct;100(10):1547-54.

PMID:
8414414
49.

High intensity 125-iodine (125I) plaque treatment of uveal melanoma.

Quivey JM, Char DH, Phillips TL, Weaver KA, Castro JR, Kroll SM.

Int J Radiat Oncol Biol Phys. 1993 Jul 15;26(4):613-8.

PMID:
8330990
50.

Radiation therapy of acquired immunodeficiency syndrome-related Kaposi's sarcoma of the eyelids and conjunctiva.

Ghabrial R, Quivey JM, Dunn JP Jr, Char DH.

Arch Ophthalmol. 1992 Oct;110(10):1423-6.

PMID:
1417543

Supplemental Content

Loading ...
Support Center